Dalton Pharma Services is a contract pharmaceutical manufacturer offering integrated chemistry, development, and manufacturing to biotechnology and pharmaceutical clients globally. Operating in a 42,000 sq. ft. facility, Dalton specializes in cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), sterile injectables, finished drug products, and solid oral dosage forms. Their capabilities cover various stages of the regulatory process from Phase I to commercial. Additionally, Dalton supports pharmaceutical research programs with a catalog of 2,500 reference standards, building blocks, metabolites, and impurities through their Dalton Research Molecules division. Established in 1986, the company’s services span from chemistry and process development to ICH stability testing, formulation, and polymorphism screening. Furthermore, they provide custom drug conjugation, targeted drug delivery systems, and analytical method development and validation. This comprehensive offering positions Dalton as a key player in the manufacturing and pharmaceutical industries, catering to the critical needs of diverse clients.
There is no investment information
No recent news or press coverage available for Dalton Pharma Services.